Carvedilol: The β-blocker of choice for portal hypertension?

Gut

Volumn 62, Issue 11, 2013, Pages 1529-1530

  Bosch, Jaime ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOSORBIDE 5 NITRATE; NADOLOL; PRAZOSIN; PROPRANOLOL;

ASCITES; BACTERIAL PERITONITIS; BAND LIGATION OF VARICES; DRUG CHOICE; DRUG WITHDRAWAL; ESOPHAGUS VARICES BLEEDING; HEPATIC VENOUS PRESSURE GRADIENT; HUMAN; HYPOTENSION; LIGATION; NOTE; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; SODIUM RETENTION; VENOUS PRESSURE;

CIRRHOSIS;

ADRENERGIC BETA-ANTAGONISTS; CARBAZOLES; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIVER CIRRHOSIS; MALE; PROPANOLAMINES;

EID: 84885653436     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-304182     Document Type: Note

References (10)

1. Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 2010;362:823-32.
2. Bosch J, Abraldes JG, Berzigotti A, et al. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009;6:573-82.
3. Tsochatzis EA, Bosch J, Burroughs AK. New therapeutic paradigm for patients with cirrhosis. Hepatology 2012;56:1983-92.
4. Bureau C, Péron JM, Alric L, et al. "A La Carte" treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology 2002;36:1361-6. (Pubitemid 35403526)
5. Abraldes JG, Albillos A, Bañares R, et al. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial. Gastroenterology 2009;136:1651-8.
6. Bosch J. Carvedilol for portal hypertension in patients with cirrhosis. Hepatology 2010;51: 2214-18.
7. Tripathi D, Ferguson JW, Kochar N, et al. Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology 2009;50: 825-33.
8. Lo GH, Chen WC, Wang HM, et al. Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding. J Gastroenterol Hepatol 2012;27:1681-7.
9. Banares R, Moitinho E, Matilla A, et al. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. Hepatology 2002;36:1367-73. (Pubitemid 35403527)
10. Reiberger T, Ulbrich G, Ferlitsch A, et al. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with hemodynamic nonresponse to propranolol. Gut 2013;62:1634-41.